Home » Topics » Regulatory » EMA

EMA
RSS

CHMP recommends European approval of once-weekly somatropin

June 3, 2013

CMDh endorses EMA committee's recommendation on benefit/risk profile of Diane-35

June 3, 2013

European CHMP recommends approval of Lojuxta

June 3, 2013

European CHMP recommends approval of pomalidomide for rrMM

June 3, 2013

BioMarin's applications for Vimizim accepted by both FDA and EMA

May 31, 2013

EMA grants orphan drug designation to Sucampo's retinitis pigmentosa therapeutic

May 30, 2013

EMA grants accelerated assessment to Gilead's MAA for sofosbuvir

May 22, 2013

EMA's CHMP recommends restricting use of Protelos/Osseor

April 29, 2013

European CHMP recommends conditional approval of Erivedge for BCC

April 29, 2013

CHMP issues positive opinion for approval of Nuedexta

April 29, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...